Literature DB >> 20551111

Geographic variations of multiple sclerosis in France.

Agnes Fromont1, Christine Binquet, Erik A Sauleau, Isabelle Fournel, Audrey Bellisario, Johan Adnet, Alain Weill, Sandra Vukusic, Christian Confavreux, Marc Debouverie, Laurence Clerc, Claire Bonithon-Kopp, Thibault Moreau.   

Abstract

France is located in an area with a medium to high prevalence of multiple sclerosis, where its epidemiology is not well known. We estimated the national and regional prevalence of multiple sclerosis in France on 31 October 2004 and the incidence between 31 October 2003 and 31 October 2004 based on data from the main French health insurance system: the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés. The Caisse Nationale d'Assurance Maladie des Travailleurs Salariés insures 87% of the French population. We analysed geographic variations in the prevalence and incidence of multiple sclerosis in France using the Bayesian approach. On the 31 October 2004, 49 417 people were registered with multiple sclerosis out of the 52 359 912 insured with the Caisse Nationale d'Assurance Maladie des Travailleurs Salariés. Among these, 4497 were new multiple sclerosis cases declared between 31 October 2003 and 31 October 2004. After standardization for age, total multiple sclerosis prevalence in France was 94.7 per 100,000 (94.3-95.1); 130.5 (129.8-131.2) in females and 54.8 (54.4-55.3) in males. The national incidence of multiple sclerosis between 31 October 2003 and 31 October 2004 was 7.5 per 100,000 (7.3-7.6); 10.4 (10.2-10.6) in females and 4.2 (4.0-4.3) in males. The prevalence and incidence of multiple sclerosis were higher in North-Eastern France, but there was no obvious North-South gradient. This study is the first performed among a representative population of France (87%) using the same method throughout. The Bayesian approach, which takes into account spatial heterogeneity among geographical units and spatial autocorrelation, did not confirm the existence of a prevalence gradient but only a higher prevalence of multiple sclerosis in North-Eastern France and a lower prevalence of multiple sclerosis in the Paris area and on the Mediterranean coast.

Entities:  

Mesh:

Year:  2010        PMID: 20551111     DOI: 10.1093/brain/awq134

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  26 in total

1.  Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.

Authors:  Amélie Darlix; Sonia Zouaoui; Jean-Marc Virion; Valérie Rigau; Hélène Mathieu-Daudé; Marie Blonski; German Reyes-Botero; Faiza Bessaoud; Brigitte Trétarre; Fabienne Bauchet; Laurent Capelle; Michel Fabbro; Christine Kerr; Dominique Figarella-Branger; Hugues Duffau; Luc Taillandier; Luc Bauchet
Journal:  J Neurooncol       Date:  2014-08-24       Impact factor: 4.130

2.  Ethical challenges in paediatric clinical trials in multiple sclerosis.

Authors:  Silvia N Tenembaum
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 3.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

4.  Short-term population-based non-linear concentration-response associations between fine particulate matter and respiratory diseases in Taipei (Taiwan): a spatiotemporal analysis.

Authors:  Hwa-Lung Yu; Lung-Chang Chien
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-04-08       Impact factor: 5.563

5.  The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination.

Authors:  Rashad Hussain; Abdel M Ghoumari; Bartosz Bielecki; Jérôme Steibel; Nelly Boehm; Philippe Liere; Wendy B Macklin; Narender Kumar; René Habert; Sakina Mhaouty-Kodja; François Tronche; Regine Sitruk-Ware; Michael Schumacher; M Said Ghandour
Journal:  Brain       Date:  2013-01       Impact factor: 13.501

6.  Estimated effects of Asian dust storms on spatiotemporal distributions of clinic visits for respiratory diseases in Taipei children (Taiwan).

Authors:  Lung-Chang Chien; Chiang-Hsing Yang; Hwa-Lung Yu
Journal:  Environ Health Perspect       Date:  2012-03-15       Impact factor: 9.031

7.  Progesterone synthesis in the nervous system: implications for myelination and myelin repair.

Authors:  Michael Schumacher; Rashad Hussain; Nathalie Gago; Jean-Paul Oudinet; Claudia Mattern; Abdel M Ghoumari
Journal:  Front Neurosci       Date:  2012-02-08       Impact factor: 4.677

8.  Environmental factors in early childhood are associated with multiple sclerosis: a case-control study.

Authors:  Silja Conradi; Uwe Malzahn; Franziska Schröter; Friedemann Paul; Sabine Quill; Eike Spruth; Lutz Harms; Florian Then Bergh; Anna Ditzenbach; Thomas Georgi; Peter Heuschmann; Berit Rosche
Journal:  BMC Neurol       Date:  2011-10-06       Impact factor: 2.474

9.  Asian dust storm elevates children's respiratory health risks: a spatiotemporal analysis of children's clinic visits across Taipei (Taiwan).

Authors:  Hwa-Lung Yu; Lung-Chang Chien; Chiang-Hsing Yang
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 10.  Use of Disease-Modifying Therapies in Pediatric MS.

Authors:  Marta Simone; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.